questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Facteurs de transcription
Facteurs de transcription EGR
Facteurs de transcription EGR : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs de transcription EGR : Questions médicales les plus fréquentes",
"headline": "Facteurs de transcription EGR : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs de transcription EGR : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription EGR"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de transcription",
"url": "https://questionsmedicales.fr/mesh/D014157",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription",
"code": {
"@type": "MedicalCode",
"code": "D014157",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-1",
"alternateName": "Early Growth Response Protein 1",
"url": "https://questionsmedicales.fr/mesh/D051766",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-1",
"code": {
"@type": "MedicalCode",
"code": "D051766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-2",
"alternateName": "Early Growth Response Protein 2",
"url": "https://questionsmedicales.fr/mesh/D051767",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-2",
"code": {
"@type": "MedicalCode",
"code": "D051767",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-3",
"alternateName": "Early Growth Response Protein 3",
"url": "https://questionsmedicales.fr/mesh/D051776",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-3",
"code": {
"@type": "MedicalCode",
"code": "D051776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription EGR",
"alternateName": "Early Growth Response Transcription Factors",
"code": {
"@type": "MedicalCode",
"code": "D051765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "John P Lydon",
"url": "https://questionsmedicales.fr/author/John%20P%20Lydon",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Elizabeth Jose",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Jose",
"affiliation": {
"@type": "Organization",
"name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Woody March-Steinman",
"url": "https://questionsmedicales.fr/author/Woody%20March-Steinman",
"affiliation": {
"@type": "Organization",
"name": "Applied Mathematics, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Lisa Shanks",
"url": "https://questionsmedicales.fr/author/Lisa%20Shanks",
"affiliation": {
"@type": "Organization",
"name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Vineet K Maurya",
"url": "https://questionsmedicales.fr/author/Vineet%20K%20Maurya",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Development and psychometric evaluation of the Implementation Science Research Project Appraisal Criteria (ImpResPAC) tool: a study protocol.",
"datePublished": "2022-12-16",
"url": "https://questionsmedicales.fr/article/36526311",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-061209"
}
},
{
"@type": "ScholarlyArticle",
"name": "Implementation science to design, test and scale up effective Kangaroo Mother Care in Oromia region, Ethiopia.",
"datePublished": "2022-06-12",
"url": "https://questionsmedicales.fr/article/35691617",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apa.16413"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using the Exploration, Preparation, Implementation, and Sustainment (EPIS) Framework to Advance the Science and Practice of Healthy Food Retail.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36642585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jneb.2022.10.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Where is \"policy\" in dissemination and implementation science? Recommendations to advance theories, models, and frameworks: EPIS as a case example.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36503520",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13012-022-01256-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Around the EQUATOR with clinician-scientists transdisciplinary aging research (Clin-STAR) principles: Implementation science challenges and opportunities.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36005482",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jgs.17993"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de transcription",
"item": "https://questionsmedicales.fr/mesh/D014157"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs de transcription EGR",
"item": "https://questionsmedicales.fr/mesh/D051765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs de transcription EGR - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs de transcription EGR",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs de transcription EGR",
"description": "Comment diagnostiquer une dysrégulation des EGR ?\nQuels tests sont utilisés pour évaluer les EGR ?\nLes EGR peuvent-ils être mesurés dans le sang ?\nQuels symptômes indiquent une anomalie des EGR ?\nLes EGR sont-ils impliqués dans des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs de transcription EGR",
"description": "Quels symptômes sont liés à une surproduction d'EGR ?\nLes EGR affectent-ils le système immunitaire ?\nQuels signes cliniques sont associés aux EGR ?\nLes EGR sont-ils liés à des troubles mentaux ?\nComment les EGR influencent-ils le développement embryonnaire ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs de transcription EGR",
"description": "Peut-on prévenir les anomalies liées aux EGR ?\nLes facteurs environnementaux influencent-ils les EGR ?\nComment réduire le risque de dysrégulation des EGR ?\nL'exercice physique influence-t-il les EGR ?\nLes suppléments nutritionnels affectent-ils les EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs de transcription EGR",
"description": "Existe-t-il des traitements ciblant les EGR ?\nComment moduler l'activité des EGR ?\nLes EGR peuvent-ils être une cible pour le cancer ?\nQuels médicaments affectent les EGR ?\nLes EGR sont-ils impliqués dans la thérapie cellulaire ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs de transcription EGR",
"description": "Quelles complications peuvent survenir avec des EGR anormaux ?\nLes EGR sont-ils liés à des maladies chroniques ?\nComment les EGR affectent-ils la santé cardiovasculaire ?\nLes EGR peuvent-ils causer des troubles neurologiques ?\nQuelles sont les conséquences d'une surproduction d'EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs de transcription EGR",
"description": "Quels facteurs augmentent le risque de dysrégulation des EGR ?\nLe stress influence-t-il les EGR ?\nL'alimentation joue-t-elle un rôle dans les EGR ?\nLes infections affectent-elles les EGR ?\nL'âge est-il un facteur de risque pour les EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=9#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des EGR ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les EGR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les Western blot sont couramment utilisés pour évaluer l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils être mesurés dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de tests sanguins standardisés pour mesurer les EGR."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des EGR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance ou des troubles neurologiques peuvent indiquer une dysrégulation."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils impliqués dans des maladies spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont associés à des maladies comme le cancer et les troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surproduction d'EGR ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner une hyperplasie cellulaire et des troubles de croissance."
}
},
{
"@type": "Question",
"name": "Les EGR affectent-ils le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils régulent la réponse immunitaire et peuvent influencer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux EGR ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, des douleurs musculaires et des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils liés à des troubles mentaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien potentiel entre les EGR et des troubles comme la dépression."
}
},
{
"@type": "Question",
"name": "Comment les EGR influencent-ils le développement embryonnaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle crucial dans la régulation des gènes nécessaires au développement embryonnaire."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies liées aux EGR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certaines anomalies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les EGR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme le stress et la pollution peuvent affecter leur expression."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de dysrégulation des EGR ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les toxines et maintenir un bon équilibre hormonal peut réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il les EGR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler l'expression des EGR et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels affectent-ils les EGR ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer leur expression."
}
},
{
"@type": "Question",
"name": "Existe-t-il des traitements ciblant les EGR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours de recherche."
}
},
{
"@type": "Question",
"name": "Comment moduler l'activité des EGR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents pharmacologiques et des modifications épigénétiques peuvent moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils être une cible pour le cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les EGR sont des cibles potentielles pour des traitements anticancéreux innovants."
}
},
{
"@type": "Question",
"name": "Quels médicaments affectent les EGR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments anti-inflammatoires peuvent influencer l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils impliqués dans la thérapie cellulaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur régulation est essentielle pour le succès des thérapies cellulaires et régénératives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des EGR anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le cancer, les maladies auto-immunes et les troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils liés à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation des EGR est associée à des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Comment les EGR affectent-ils la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une régulation anormale des EGR peut contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils causer des troubles neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans l'expression des EGR sont liées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une surproduction d'EGR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner des tumeurs et des désordres de croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysrégulation des EGR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les EGR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter l'expression des EGR et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les EGR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut aider à réguler l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les infections affectent-elles les EGR ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent moduler l'expression des EGR, influençant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les EGR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter l'expression des EGR et la régulation génétique."
}
}
]
}
]
}
The need for quantitative criteria to appraise the quality of implementation research has recently been highlighted to improve methodological rigour. The Implementation Science Research development (I...
This study employs a three-stage sequential mixed-methods design. During stage 1, the research team will map core domains of the ImpRes tool, guidance and recommendations contained in the supplementar...
This study will involve human participants. This study has been registered and minimal risk ethical clearance granted by The Research Ethics Office, King's College London (reference number MRA-20/21-2...
To develop a locally tested and optimised Kangaroo Mother Care (KMC) scale-up model to achieve high population-based effective coverage of KMC in Oromia region....
We conducted an implementation research study to design and test KMC scale-up models from March 2017 to March 2019 in five hospitals and 39 health centres covering a population of 1.1 million in Oromi...
After three cycles of iterative model implementation, we developed a KMC scale-up model that resulted in increased population-based effective KMC coverage. We enhanced the existing health system by st...
Through iterative testing and adaptations, a model to scale up KMC that achieves 54% population-based effective coverage of KMC can be developed....
Although healthy food retail strategies are widely used, there appears to be a limited understanding of the processes and determinants for successful adoption, implementation, and sustainment. To fill...
Implementation science aims to accelerate the public health impact of evidence-based interventions. However, implementation science has had too little focus on the role of health policy - and its inse...
(1) Specify dimensions of a policy's function (policy goals, type, contexts, capital exchanged). (2) Specify dimensions of a policy's form (origin, structure, dynamism, outcomes). (3) Identify and def...
Researchers should use TMF to meaningfully conceptualize policy's role in D&I efforts to accelerate the public health impact of evidence-based policies or practices and de-implement ineffective and ha...
The Institute of Medicine and the National Institute on Aging increasingly understand that knowledge alone is necessary but insufficient to improve healthcare outcomes. Adapting the behaviors of clini...
Despite many evidence-based adolescent and young adult (AYA) HIV interventions, few are implemented at scale in sub-Saharan Africa (SSA). A growing implementation science literature provides important...
Disease burden of venous thromboembolism (VTE) without pharmacologic prophylaxis is high in trauma patients. Although VTE prophylaxis guidelines exist, studies on real-world use of VTE prophylaxis in ...
Adolescent mental health (AMH) is a critical driver of HIV outcomes, but is often overlooked in HIV research and programming. The implementation science Exploration, Preparation, Implementation, Susta...
The host-pathogen relationship is inherently dynamic and constantly evolving. Applying an implementation science lens to policy evaluation suggests that policy impacts are variable depending upon key ...
Experiences with non-pharmaceutical interventions (NPIs) including masking, testing, and social distancing/business and school closures during the COVID-19 pandemic response highlight the importance o...
Updating public health policy recommendations as more data and alternative interventions become available is the evidence-based policy approach and grounded in principles of implementation science and...
Real-time decision making requires sensitivity to conditions on the ground and adaptation of interventions at all levels. When asking about the public health effectiveness and impact of non-pharmaceut...
To address maternal iron-deficiency anemia and low uptake of iron and folic acid supplementation (IFAS) among antenatal care (ANC) clinic attendees in East-Central Uganda, the Anemia Implementation Sc...
To address 2 bottlenecks of stock-outs and inadequate health education for pregnant women during ANC, an enhanced QI intervention was implemented from July 2019 to September 2020 in 2 districts. We co...
The intervention increased the probability, at a statistically significant level, of pregnant women both receiving IFAS and receiving health education on IFAS during ANC. According to inter-viewees, t...
The intervention successfully addressed the 2 main bottlenecks to availability of IFAS for pregnant women attending ANC-inadequate provision of IFAS education and a weak drug quantification process. E...